AMBBY Company Profile and Key Details

Q: Who are the executives of AMBBY?

Mr. Henrik AnkjærExecutive Vice President of Global OperationsMikkel Trier WagnerDirector of Corporation CommunicationsMr. Bassel RifaiExecutive Vice President, Chief Marketing Officer & Pres APACMs. Britt Meelby JensenChief Executive OfficerMr. Steven R. BlockChief Executive Officer & Pres of USAMr. Thomas Frederik SchmidtExecutive Vice President & Chief Financial OfficerMr. Anders F. WilliamssonManaging DirectorMr. Måns BarsneExecutive Vice President of Global Innovation & Chief Innovation OfficerMr. Thomas Lykke HenriksenHead of HR SystemsHolger HesseFounderMr. Nicolai ThomsenDirector of Investor Relations & Strategic Financial Planning

PNK : AMBBY

Ambu A/S

$18.62

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ambu A/S (AMBBY) stock remained unchanged at $13.82 a share on OTC. The stock opened at $13.82, fluctuating between $13.82 to $13.82 during the session.

Stock Snapshot

13.82

Prev. Close

3.68B

Market Cap

13.82

Day Low

43.19

P/E Ratio

0.32

EPS (TTM)

1.88

Cash Flow per Share

13.82

Open

266.24M

Number of Shares

13.82

Day High

64.86%

Free Float in %

20.36

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2026	13.81	13.85	13.81	13.82	3.2K
Feb 03, 2026	13.20	13.20	13.20	13.20	1K
Jan 30, 2026	13.53	13.53	13.53	13.53	541
Jan 29, 2026	13.53	13.53	13.53	13.53	2K
Jan 26, 2026	13.78	13.78	13.78	13.78	542
Jan 21, 2026	13.88	13.88	13.57	13.57	700
Jan 16, 2026	14.18	14.18	14.18	14.18	1K
Jan 09, 2026	13.80	13.80	13.80	13.80	500
Jan 05, 2026	13.58	13.58	13.58	13.58	500
Dec 31, 2025	13.20	13.20	13.20	13.20	1.54K
Dec 17, 2025	13.60	13.60	13.60	13.60	190
Dec 15, 2025	13.78	13.78	13.78	13.78	500
Dec 09, 2025	13.33	13.33	13.33	13.33	500
Dec 08, 2025	13.53	13.53	13.53	13.53	300
Nov 25, 2025	13.59	13.59	13.59	13.59	333
Nov 13, 2025	13.20	13.20	13.20	13.20	137
Nov 11, 2025	12.96	12.96	12.96	12.96	500
Nov 07, 2025	12.55	12.55	12.55	12.55	1
Nov 05, 2025	12.56	12.56	12.56	12.56	544
Nov 04, 2025	15.15	15.15	14.38	14.38	2.65K

Contact Details

Ballerup, 2750

Denmark

https://www.ambu.com 457 225 2000

About Company

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, head immobilizers, CPR breathing barriers, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Stock Peers

SONVF

Sonova Holding AG$321.70 CHEOF

Cochlear Limited$205.50 CHEOY

-0.98-0.89%

Cochlear Limited$108.73 GNNDY

GN Store Nord A/S$91.91 SONVY

0.11+0.17%

Sonova Holding AG$63.73 SEMHF

Siemens Healthineers AG$58.50 WILLF

Demant A/S$45.88 XVIPF

-0.33-0.77%

Xvivo Perfusion AB (publ)$42.76 SMMNY

-0.43-1.46%

Siemens Healthineers AG$29.03 RYLPF

Koninklijke Philips N.V.$27.15

Company Overview

The stock is currently mid-range between its 52-week high and low $12.56 and $20.24. With a market capitalization of about $3.68 billion, Ambu A/S is classified as a mid-cap and shows higher-than-market volatility (beta ~1.45). Key stats such as the average daily volume over the past year has been around 213.00 shares, trading with heavier-than-usual volume. Headquartered in Ballerup, None, Ambu A/S operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Britt Meelby Jensen, the company employs approximately 5,000 people and listed since January 08, 2021. Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.

Technical Performance

Average 10-day trading volume of 2.10 thousand shares is significantly above the 3-month average of 822.29, indicating heightened recent market interest.

Valuation Metrics

Ambu A/S trades at a P/E ratio of 42.8, slightly above the S&P 500 average, with a price-to-sales ratio of -1.23 and a price-to-book ratio of 3.85 trading at moderately above to book value. The P/FCF stands at 46.58, also above market averages.

Dividend & Fair Value

Ambu A/S last paid a dividend of 0.03 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.08. This means the shares are trading above this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Ambu A/S generated $6.04B in revenue, or $22.61 per share. Gross margin was 55.97%, operating margin 12.99%, and net profit margin 10.09%. Returns are healthy, with ROA at 7.93% and ROE at 10.09%.
On valuation metrics, Ambu A/S trades at a P/E of 42.80, P/S of -1.23 and P/B of 3.85. The current ratio is 2.86 and quick ratio is 1.67. Operationally, the company’s inventory turnover is -5.68 and cash conversion cycle is -54.53 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.09, supported by a cash flow-to-debt ratio of 1.36.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, Ambu A/S posted revenue of $6.04B, down slightly from $5.39B in the prior quarter. Gross profit was $3.38B (margin 55.97%). Operating income was $784.00M (margin 13.0%). Net income was$609.00M (EPS $2.29).
The company ended the quarter with $866.00M in cash and short-term investments, a total debt of $547.00M, and net debt of - $319.00M. Total assets were $7.68B, with equity of $6.04B. Financials further reflected stability, with operating cash flow of $791.00M, free cash flow of $674.00M, and capital expenditures of - $117.00M.

Price Forecast & Outlook

Our AI price prediction model suggests that Ambu A/S stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Ambu A/S trading at a premium to the broader market with a P/E of 42.8.

Frequently Asked Questions

What is the current Ambu A/S (AMBBY) stock price?

Ambu A/S (OTC: AMBBY) stock price is $13.82 in the last trading session. During the trading session, AMBBY stock reached the peak price of $13.82 while $13.82 was the lowest point it dropped to. The percentage change in AMBBY stock occurred in the recent session was 0% while the dollar amount for the price change in AMBBY stock was $0.00.

AMBBY's industry and sector of operation?

The OTC listed AMBBY is part of Medical - Devices industry that operates in the broader Healthcare sector. Ambu A/S designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AMBBY?

Mr. Henrik Ankjær
Executive Vice President of Global Operations
Mikkel Trier Wagner
Director of Corporation Communications
Mr. Bassel Rifai
Executive Vice President, Chief Marketing Officer & Pres APAC
Ms. Britt Meelby Jensen
Chief Executive Officer
Mr. Steven R. Block
Chief Executive Officer & Pres of USA
Mr. Thomas Frederik Schmidt
Executive Vice President & Chief Financial Officer
Mr. Anders F. Williamsson
Managing Director
Mr. Måns Barsne
Executive Vice President of Global Innovation & Chief Innovation Officer
Mr. Thomas Lykke Henriksen
Head of HR Systems
Holger Hesse
Founder
Mr. Nicolai Thomsen
Director of Investor Relations & Strategic Financial Planning

How AMBBY did perform over past 52-week?

AMBBY's closing price is 97.04% higher than its 52-week low of $12.56 where as its distance from 52-week high of $20.24 is -5.72%.

How many employees does AMBBY have?

Number of AMBBY employees currently stands at 5,000.

Link for AMBBY official website?

Official Website of AMBBY is: https://www.ambu.com

How do I contact AMBBY?

AMBBY could be contacted at phone 457 225 2000 and can also be accessed through its website. AMBBY operates from Baltorpbakken 13, Ballerup, 2750, Denmark.

How many shares of AMBBY are traded daily?

AMBBY stock volume for the day was 1K shares. The average number of AMBBY shares traded daily for last 3 months was 213.

What is the market cap of AMBBY currently?

The market value of AMBBY currently stands at $3.68B with its latest stock price at $13.82 and 266.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5000
Beta	1.45
Sales or Revenue	$6.04B
5Y Sales Change%	0.709%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Medical - Devices

AMBBY Company Profile and Key Details

Ambu A/S

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways